Task: Answer the multiple choice question.
Question: Which drug exhibits a -34.686% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCC1Oc2ccc(C)cc2N(CC(=O)NCCCN2CCCC2)C1=O
(b) COc1ccc(CCN2C(=O)C3C4CCC(C4=C(C)C)C3C2=O)cc1OC
Answer: a. CCC1Oc2ccc(C)cc2N(CC(=O)NCCCN2CCCC2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1Oc2ccc(C)cc2N(CC(=O)NCCCN2CCCC2)C1=O
CCC1Oc2ccc(C)cc2N(CC(=O)NCCCN2CCCC2)C1=O
2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-(3-pyrrolidin-1-ylpropyl)acetamide